Antifungal coating by biofunctionalized polyelectrolyte multilayered films

被引:111
作者
Etienne, O
Gasnier, C
Taddei, C
Voegel, JC
Aunis, D
Schaaf, P
Metz-Boutigue, MH
Bolcato-Bellemin, AL
Egles, C
机构
[1] Inst Natl Sante & Rech Med, Unite 595, F-67085 Strasbourg, France
[2] Univ Strasbourg 1, Fac Chirurgie Dent, F-67000 Strasbourg, France
[3] Inst Natl Sante & Rech Med, Unite 575, F-67085 Strasbourg, France
[4] Univ Strasbourg 1, CNRS, Inst Charles Sadron, UPR 22, F-67083 Strasbourg, France
关键词
antimicrobial; bioactivity; surface modifications; polyelectrolyte multilayer film; chromofungin; chromogranin A;
D O I
10.1016/j.biomaterials.2005.04.068
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The surface of medical devices is a common site of bacterial and fungal adhesion. first step to the constitution of a resistant biofilm leading frequently to chronic infections. In order to prevent Such complications. several physical and chemical modifications of the device surface have been proposed. Here, we experiment a new type of topical antifungal coating using the layer-by-layer technique. The nanometric multilayer thin obtained by this technique is functionalized. by the insertion of a chromogranin A-derived antifungal peptide (CGA 47-66, chromofungin). We show that the embedded peptide keeps its antifungal activity by interacting with the fungal membrane and penetrating into the cell. In vitro studies demonstrate that Such an antifungal Coating is able to inhibit the growth of yeast Candida albicans by 65% and completely stop the proliferation of filamentous fungus Neurospora crassa. The cytotoxicity of such a coating was also assessed by growing human gingival fibroblasts at its surface, Finally the antifungal coating of poly(methylmethacrylate), a widely used material for biomedical devices, is successfully tested in tit in vivo oral candidiasis rat model. Taken together, these results assessed the functionalized multilayer films containing a new potent antifungal non-toxic peptide, as a novel and promising technique for local antifungal protection. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6704 / 6712
页数:9
相关论文
共 21 条
[1]   Immune-deficient Drosophila melanogaster:: A model for the innate immune response to human fungal pathogens [J].
Alarco, AM ;
Marcil, A ;
Chen, J ;
Suter, B ;
Thomas, D ;
Whiteway, M .
JOURNAL OF IMMUNOLOGY, 2004, 172 (09) :5622-5628
[2]   Expression of mRNAs encoding for α and β integrin subunits, MMPs, and TIMPs in stretched human periodontal ligament and gingival fibroblasts [J].
Bolcato-Bellemin, AL ;
Elkaim, R ;
Abehsera, A ;
Fausser, JL ;
Haikel, Y ;
Tenenbaum, H .
JOURNAL OF DENTAL RESEARCH, 2000, 79 (09) :1712-1716
[3]   Polyelectrolyte multilayer films with pegylated polypeptides as a new type of anti-microbial protection for biomaterials [J].
Boulmedais, F ;
Frisch, B ;
Etienne, O ;
Lavalle, P ;
Picart, C ;
Ogier, J ;
Voegel, JC ;
Schaaf, P ;
Egles, C .
BIOMATERIALS, 2004, 25 (11) :2003-2011
[4]   Assembly of alternating polyelectrolyte and protein multilayer films for immunosensing .2. [J].
Caruso, F ;
Niikura, K ;
Furlong, DN ;
Okahata, Y .
LANGMUIR, 1997, 13 (13) :3427-3433
[5]  
DECHER G, 1997, SCIENCE, V277, P5330
[6]   Multilayer polyelectrolyte films functionalized by insertion of defensin: A new approach to protection of implants from bacterial colonization [J].
Etienne, O ;
Picart, C ;
Taddei, C ;
Haikel, Y ;
Dimarcq, JL ;
Schaaf, P ;
Voegel, JC ;
Ogier, JA ;
Egles, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (10) :3662-3669
[7]   Fungal biofilms and drug resistance [J].
Jabra-Rizk, MA ;
Falkler, WA ;
Meiller, TF .
EMERGING INFECTIOUS DISEASES, 2004, 10 (01) :14-19
[8]  
Kanno T, 1999, EXP PHYSIOL, V84, P1073
[9]   Poly(L-lysine)-g-poly(ethylene glycol) layers on metal oxide surfaces:: Attachment mechanism and effects of polymer architecture on resistance to protein adsorption [J].
Kenausis, GL ;
Vörös, J ;
Elbert, DL ;
Huang, NP ;
Hofer, R ;
Ruiz-Taylor, L ;
Textor, M ;
Hubbell, JA ;
Spencer, ND .
JOURNAL OF PHYSICAL CHEMISTRY B, 2000, 104 (14) :3298-3309
[10]  
Kuhn Duncan M, 2004, Curr Opin Investig Drugs, V5, P186